Contralateral papillary thyroid cancer: does size matter?

American Journal of Surgery

Volumn 197, Issue 3, 2009, Pages 342-347

  Pitt, Susan C ^a   Sippel, Rebecca S ^a   Chen, Herbert ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Contralateral; Microcarcinoma; Papillary thyroid cancer; Risk factors; Size

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA, PAPILLARY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY; YOUNG ADULT;

EID: 60549113333     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.09.011     Document Type: Article

References (30)

1. Davies L., and Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295 (2006) 2164-2167
2. American Cancer Society. Cancer facts and figures 2008. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf Accessed: July 1, 2008
3. Mitchell I., Livngston E.H., Chang A.Y., et al. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery 142 (2007) 823-828
4. Hodgson N.C., Button J., and Solorzano C.C. Thyroid cancer: is the incidence still increasing?. Ann Surg Oncol 11 (2004) 1093-1097
5. Smailyte G., Miseikyte-Kaubriene E., and Kurtinaitas J. Increasing thyroid cancer incidence in Lithuania in 1978-2003. BMC Cancer 6 (2006) 284
6. Scheiden R., Keitpes M., Bock C., et al. Thyroid cancer in Luxembourg: a national population-based (1983-1999). BMC Cancer (2006) 102
7. Reynolds R.M., Weir J., Stockton D.L., et al. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Enocrinol (Oxf) 62 (2005) 156-162
8. Leenhardt L., Grosclaude P., and Cherie-Challine L. Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects?. Report from the French Thyroid Cancer Committee. Thyroid 14 (2004) 1056-1060
9. Liu S., Semenciw R., Ugnat A.M., et al. Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer 85 (2001) 1335-1339
10. Llyod R., DeLellis R., and Heitz P. World Health Organization Classification of Tumours: pathology and genetics of tumours of the endocrine organs (2004), IARC, Lyon, France
11. Billmoria K.Y., Bentrem D.J., Ko C.Y., et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246 (2007) 375-384
12. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 109-141
13. Schönberger J., Marienhagen J., Agha A., et al. Papillary microcarcinoma and papillary cancer of the thyroid ≤ 1 cm: modified definition of the WHO and the therapeutic dilemma. Nuklearmedizin 46 (2007) 115-120
14. Pasieka J.L., Thompson N.W., McLeod M.K., et al. The incidence of bilateral well-differentiated thyroid cancer found at completion thyroidectomy. World J Surg 16 (1992) 711-716
15. Chow S., Law S.C.K., Chan J.K.C., et al. Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer 98 (2003) 31-40
16. Grigsby P.W., Reddy R.M., Moley J.F., et al. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment. Surgery 140 (2006) 1043-1047
17. Pacini F., Elisei R., Capezzone M., et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 11 (2001) 877-881
18. Miccoli P., Minuto M.N., Ugolini C., et al. Intrathyroidal differentiated thyroid carcinoma: tumor size-based surgical concepts. World J Surg 31 (2007) 888-894
19. Kawura M., Pathak I., Gullane P.J., et al. Multicentricity in papillary thyroid carcinoma: analysis of predictive factors. J Otolaryngol 30 (2001) 102-105
20. Kim E.S., Kim T.Y., Koh J.M., et al. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol 61 (2004) 145-148
21. Küçük N.O., Tari P., Tokmak E., et al. Treatment for microcarcinoma of the thyroid-clinical experience. Clin Nucl Med 32 (2007) 279-281
22. Ito Y., Uruno T., Nakano K., et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13 (2003) 381-387
23. Shattuck T.M., Westra W.H., Ladenson P.W., et al. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid cancer. N Engl J Med 352 (2005) 2406-2412
24. Osmólski A., Frenkiel Z., and Osmólski R. Complications in surgical treatment of thyroid diseases. Otolaryngol Pol 60 (2006) 165-170
25. Farkas E.A., King T.A., Bolton J.S., et al. A comparison of total thyroidectomy and lobectomy in the treatment of dominant thyroid nodules. Am Surg 68 (2002) 678-682
26. Rafferty M.A., Goldstein D.P., Rotstein L., et al. Completion thyroidectomy versus total thyroidectomy: is there a difference in complication rates?. An analysis of 350 patients. J Am Coll Surg 205 (2007) 602-607
27. Pellegriti G., Scollo C., Lumera G., et al. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89 (2004) 3713-3720
28. Nam-Goong I.S., Kim H.Y., Gong G., et al. Ultrasound-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Enocrinol (Oxford) 60 (2004) 21-28
29. Cheema Y., Repplinger D., Elson D., et al. Is tumor size the best predictor of outcome for papillary thyroid cancer?. Ann N Oncol 13 (2006) 1524-1528
30. Ito Y., Uruno T., Nakano K., et al. An observational trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13 (2003) 381-387